Discrimination of N2a and N2b by EBUS-TBNA: is a Change of the Needle Necessary?

Recruiting now · Not applicable

Conditions studied: Lung Cancer (Diagnosis)

In brief

During EBUS staging in patients with mediastinal lymphadenopathy, it is planned to perform a first round of staging with change of the needle between all lymph nodes and a second round of staging without change of the needle.

Key facts

Study ID

NCT07418450

Run by

University of Vienna

People needed

30

Starts

2025-11-05

Expected to finish

2027-05-01

Last updated by the study team

2026-02-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Pulmonary lesion suspicious for lung cancer or histologically confirmed lung cancer
• indication for mediastinal staging

Where it is running

• Medical University of Vienna — Vienna, Austria (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.